Cryptocurrencies
PTC Therapeutics Grabs Up to $1 Billion, but There’s a Catch
The drug developer’s financing deal with Blackstone has several strings attached. The biotech sector has been whacked during the stock market correction, but companies with approved drug products have generally fared much better than early-stage Read more…